Full-dose CHOP chemotherapy combined with granulocyte colony-stimulating factor for aggressive non-Hodgkin's lymphoma in elderly patients: A prospective study

Annals of Hematology

Volumn 80, Issue 10, 2001, Pages 602-606

  Niitsu, N ^a   Iijima, K ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CHOP; Elderly; Granulocyte colony stimulating factor; Non Hodgkin's lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; PREDNISONE; VINCRISTINE;

AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; GASTROINTESTINAL HEMORRHAGE; GERIATRIC PATIENT; GRANULOCYTOPENIA; HEALTH STATUS; HEART FAILURE; HIGH RISK PATIENT; HUMAN; MALE; NONHODGKIN LYMPHOMA; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL RATE;

AGED; AGING; AGRANULOCYTOSIS; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; PREDNISONE; PROGNOSIS; PROSPECTIVE STUDIES; REMISSION INDUCTION; SURVIVAL RATE; VINCRISTINE;

EID: 0035163585     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770100358     Document Type: Article

References (19)

1. Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly. Increased complications of advancing age
2. The chemotherapy of lymphoma-looking back, moving forward: The Richard and Hinda Rosenthal Foundation Award Lecture
3. Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: The Southwest Oncology Group experience
4. Full dose CHOP chemotherapy in elderly patients with non-Hodgkin's lymphoma
5. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma
6. The importance of dose intensity in chemotherapy of metastatic breast cancer
7. Nonparametric estimation from incomplete observation
8. Prognostic significance of actual dose intensity in diffuse large-cell lymphoma - Results of a tree - Structured survival analysis
9. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma
10. A phase I trial of standard and cyclophosphamide dose-escalated CHOP with granulocyte colony stimulating factor in elderly patients with non-Hodgkin's lymphoma
11. Optimal dose of CHOP for treatment completion in elderly non-Hodgkin's lymphoma patients
12. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group
13. THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for non-Hodgkin's lymphoma in elderly patients: A prospective study
14. Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphoma: Experience of the non-Hodgkin's lymphoma pathologic classification project
15. A predictive model for aggressive NHL: The International Non-Hodgkin's Lymphoma Prognostic Factors Project
16. A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma
17. The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma
18. Handbook for reporting results of cancer treatment